Treating Infertility

Today we are thrilled to have Dr. Emily Seidler of the Division of Reproductive Endocrinology and Infertility at Beth Israel Deaconess and Boston IVF, come help us revisit Infertility with a discussion on treatment. We start out with definitions of fecundity versus fecundability, meaning:

  • Fecundity: Fertility; the ability to conceive and produce offspring, vs.

  • Fecundability = probability of getting pregnant in a single menstrual cycle.

For the first six months of attempted conception, 80% of couples will succeed. After one year, this jumps to about 85%, leaving a 15% rate of infertility overall based on the definitions we reviewed in our prior infertility episode.

Patients/couples should be initially counseled on lifestyle modification to improve fertility:

  • Stop smoking.

  • Reducing excessive alcohol/caffeine consumption.

  • Weight loss to target normal BMI.

  • Appropriately timing intercourse just before/around time of ovulation.

    • Use of OPKs starting around CD10

  • Once health and lifestyle is (reasonably) optimized, treatment may still be needed and varies depending on cause of subfertility/infertility.

We then started to talk about the specific causes of infertility. The first and most broad is ovulatory dysfunction. Ovulatory dysfunction is broken into major categories by the World Health Organization (WHO):

  • WHO class 1: hypogonadotropic hypogonadal anovulation (5-10%)

    • Common causes of this include anorexia, over-exercising, or Kallman’s and Sheehan’s syndromes.

    • These women need extensive nutritional support and hormonal support for bone and heart health.

    • To conceive, this group of patients will need injectable gonadotropins.

  • WHO class 2 = Normogonadatropic normoestrogenic (70-85%)

    • The most common example in this group is PCOS.

    • Treatment should focus on optimizing health (weight loss, improve/control insulin resistance, etc.) then ovulation induction with timed intercourse.

    • Letrozole is first line ovulation induction agent with PCOS.

      • NEJM 2014 comparing Clomiphene and Letrozole for PCOS.

        • Showed LTZ was associated with higher ovulation rates and higher live brith rates.

      • Clomiphene can also be used if can’t use letrozole or patient doesn’t respond to letrozole.

      • Clomiphene & Letrozole have different mechanisms of action but similar end result:

        • Clomid works at the level the brain as a SERM to inhibit negative feedback of estrogen on GnRH and FSH production/release.

        • Letrozole works at the level of the ovary and is an aromatase inhibitor, thus reducing the amount of estrogen available and pushing more production of FSH.

          • Both trick the brain into thinking estrogen is low, so FSH goes up.

  • WHO class 3 = hypergonadotropic hypoestrogenic anovulation (10-25%)

    • Classically described as primary ovarian insufficiency (POI)

    • Some can go through treatment with their own eggs, but often FSH is very elevated and AMH/AFC are very low- these patients generally need IVF donor eggs to conceive.

Next, we moved beyond ovulation to other causes of infertility.

Tubal factor:

  • I.e., both tubes are blocked.

  • Treatment is IVF, as this is only way to bypass the tubes in this case.

  • If hydrosalpinx, consider removing prior to treatment (these reduce pregnancy rate by 50% after embryo transfer when left in situ).

Male factor:

  • If sperm is present but in low counts (generally under ~4 mil total motile sperm), IVF with ICSI is helpful

    • ICSI = intracytoplasmic sperm injection.

      • One sperm injected into each egg under the microscope

  • If azospermic but male factor is an obstructive cause (i.e., cystic fibrosis patients with congenital absence of vas deferens), can surgically obtain sperm with TESE (testicular sperm extraction).

  • If azospermic and non-obstructive (i.e., patient isn’t making sperm), need donor sperm for conception.

Uterine factor:

  • This is generally not an independent cause of infertility or reason, in isolation, for surgical intervention.

  • However, when uterine factors that affect the cavity are found in an infertility evaluation, these are typically corrected prior to treatment.

    • Submucosal fibroids and endometrial polyps can be removed hysteroscopically .

    • Uterine septum or intracavitary adhesions can be resected hysteroscopically with cold scissors or with energy.

Unexplained infertility:

  • Testing all normal but unable to conceive after 6-12 mos; includes age-related subfertility.

    • Treatment is empiric (“cover the bases” approach).

      • Can start with medicated IUI with Clomiphene or Letrozole

      • If unable to conceive after 3-4 cycles, move on to IVF.

  • IVF can involve a fresh embryo transfer on day 3 or day 5, or frozen embryo transfers (always day 5).

  • Prenatal genetic testing for aneuploidy (PGT-A) is an adjunct to treatment (formerly called PGS).

    • This involves a trophectoderm biopsy at the blastocyst stage

      • Trophectoderm becomes the placenta; inner cell mass becomes the fetus.

    • Embryos generally are then frozen and biopsy samples are tested to determine chromosomal status 

      • Used as a selection tool to transfer a single euploid embryo

        • Theoretically increases pregnancy rate to 60-70% and decreases miscarriage rate to 10%

        • However, recent studies (i.e., STAR trial) haven’t shown huge benefit to PGT-A over standard morphologic criteria for embryo evaluation.

Same sex couples/single patients:

  • Same sex female couples have options various therapies vs. traditional IVF

    • TDI = therapeutic donor insemination.

      • simply timing insemination with one partner’s menstrual cycle and using donor sperm.

      • Can also utilize ovulation induction techniques (i.e., letrozole/clomiphene).

    • Partner-assisted Reproduction (PAR), aka reciprocal IVF = using one partner’s eggs for conception, but the other partner carries the pregnancy.

      • Ovarian stimulation and egg retrieval on one partner.

      • Create embryos with donor sperm.

      • Transfer the embryo(s) into the other partner’s uterus.

    • Traditional IVF particularly if one partner is unable to conceive using TDI.

  • Same sex male couples require donor egg + gestational carrier.

    • Gestational carrier: just carrying the pregnancy.

      • Donor egg from a different woman; embryos created with one of the male partner’s sperm,

      • Traditional surrogacy typically refers to using the carrying woman’s egg, as well as her uterus. This has become very complicated legally and ethically and thus is not used with frequency.

Polycystic Ovarian Syndrome (PCOS)

Big shout out to Andrey Dolinko, MD, who suggested today’s topic!
ACOG PB 194 is an excellent resource for your studying on PCOS (membership required).

PCOS is a syndrome, diagnosed clinically by at least 2/3 of the Rotterdam criteria:
1. Hyperandrogenism - hirsutism, male pattern baldness.
2. Oligo- or amenorrhea - 3+ months without menses.
3. Polycystic ovaries on ultrasound - 12+ follicles or increased ovarian volume.

In terms of treatment, the big take home message is to understand whether your patient is planning on pregnancy or not. CHCs are the mainstay therapy of patients not desiring pregnancy due to their multimodal method of action - regulation of HPO axis, increased SHBG, and endometrial protection. Also remember metformin (insulin sensitization) and spironolactone, finasteride, or flutamide (anti-androgens) as other adjuncts in patients not desiring pregnancy.

In those desiring pregnancy, oftentimes the complaint will be infertility. While letrozole is now preferred for ovulation induction over clomiphene due to a higher live-birth rate, letrozole does not yet enjoy FDA approval. For the other symptoms of PCOS in patients desiring pregnancy, the first line therapy is lifestyle modification! The literature doesn’t support metformin for ovulation induction, but some may use it for its other benefits prior to pregnancy.

We didn’t discuss laparoscopic ovarian drilling in this episode, but that would be another surgical treatment for PCOS-related infertility.

Diagnosis and Workup of Secondary Amenorrhea

Today's topic will be a follow up of last week: diagnosis and workup of secondary amenorrhea. This will be a broad overview, with much more detail to follow in the future! 

Again, the ASRM guidelines for amenorrhea are a helpful resource for further reading.

Additionally, the American Academy of Family Physicians (AAFP) has a guideline publication on amenorrhea. While it’s a bit outdated, they do supply a chart that can be a helpful framework for your studying or diagnostic evaluation!

And remember… did you get that pregnancy test yet?

Diagnosis and Workup of Primary Amenorrhea

Today's topic will be a broad overview of the diagnosis and workup of primary amenorrhea... There’s a lot to take in, but don't worry! There will more to come on each of the topics that we touch on down the line. 

Fei has made a handy chart for thinking about primary amenorrhea below!

For further reading on primary amenorrhea, see the ASRM guideline on amenorrhea.
And remember… always check a pregnancy test.